Abnormal PI3 kinase/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats

Molecular Brain Research

Volumn 110, Issue 2, 2003, Pages 234-244

  Cai, Fang ^a   Helke, Cinda J ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Autonomic nerve; Axonal transport; Experimental diabetes; Nodose ganglia; p70s6 kinase

Indexed keywords

NEUROTROPHIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P70S6 KINASE; PROTEIN P85; SERINE; THREONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; RETROGRADE NERVE FIBER TRANSPORT; SENSORY NERVE; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; VAGUS NERVE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; AXONAL TRANSPORT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; IMMUNOHISTOCHEMISTRY; MALE; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURONS, AFFERENT; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; VAGUS NERVE; VAGUS NERVE DISEASES;

ANIMALIA;

EID: 0037456070     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00652-6     Document Type: Article

References (60)

1. Alessi D.R., Kozlowski M.T., Weng Q.P., Morrice N., Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8:1998;69-81.
2. Anand P., Terenghi G., Warner G., Kopelman P., Williams-Chestnut R.E., Sinicropi D.V. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat. Med. 2:1996;703-707.
3. 125I-betaNGF. Brain Res. 761:1997;257-262.
4. Bellacosa A., Chan T.O., Ahmed N.N., Datta K., Malstrom S., Stokoe D., McCormick F., Feng J., Tsichlis P. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene. 17:1998;313-325.
5. Berven L.A., Crouch M.F. Cellular function of p70S6K: a role in regulating cell motility. Immunol. Cell Biol. 78:2000;447-451.
6. Cameron N.E., Cotter M.A., Archibald V., Dines K.C., Maxfield E.K. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia. 37:1994;449-459.
7. Carvalho E., Eliasson B., Wesslau C., Smith U. Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from Type II diabetic subjects. Diabetologia. 43:2000;1107-1115.
8. Crowder R.J., Freeman R.S. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18:1998;2933-2943.
9. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
10. LNTR protein in lumbar dorsal root ganglia. Mol. Brain Res. 51:1997;82-90.
11. Delcroix J.D., Michael G.J., Priestley J.V., Tomlinson D.R., Fernyhough P. Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozocin-induced diabetic rats. Diabetes. 47:1998;1779-1785.
12. Dolcet X., Egea J., Soler R.M., Martin-Zanca D., Comella J.X. Activation of phosphatidylinositol 3-kinase, but not extracellular-regulated kinases, is necessary to mediate brain-derived neurotrophic factor-induced motoneuron survival. J. Neurochem. 73:1999;521-531.
13. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
14. Estrada D.E., Ewart H.S., Tsakiridis T., Volchuk A., Ramlal T., Tritschler H., Klip A. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes. 45:1996;1798-1804.
15. Faradji V., Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol. Scand. 81:1990;402-406.
16. Fernyhough P., Diemel L.T., Brewster W.J., Tomlinson D.R. Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience. 62:1994;337-344.
17. Fernyhough P., Gallagher A., Averill S.A., Priestley J.V., Hounsom L., Patel J., Tomlinson D.R. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes. 48:1999;881-889.
18. Hansen T., Andersen C.B., Echwald S.M., Urhammer S.A., Clausen J.O., Vestergaard H., Owens D., Hansen L., Pedersen O. Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes. 46:1997;494-501.
19. Hansen L.L., Ikeda Y., Olsen G.S., Busch A.K., Mosthaf L. Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance. J. Biol. Chem. 274:1999;25078-25084.
20. Helke C.J., Adryan K.M., Fedorowicz J., Zhuo H., Park J.S., Curtis R., Radley H.E., Distefano P.S. Axonal transport of neurotrophins by visceral afferent and efferent neurons of the vagus nerve of the rat. J. Comp. Neurol. 393:1998;102-117.
21. Hellweg R., Hartung H.-D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26:1990;258-267.
22. Hellweg R., Raivich G., Hartung H.-D., Hock C., Kreutzberg G.W. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp. Neurol. 130:1994;24-30.
23. Hetman M., Kanning K., Cavanaugh J.E., Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274:1999;22569-22580.
24. Jackson T.R., Blader I.J., Hammonds-Odie L.P., Burga C.R., Cooke F., Hawkins P.T., Wolf A.G., Heldman K.A., Theibert A.B. Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase. J. Cell Sci. 109:(Pt 2):1996;289-300.
25. Jiang Z.Y., Zhou Q.L., Chatterjee A., Feener E.P., Myers M.G. Jr., White M.F., King G.L. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes. 48:1999;1120-1130.
26. Kandel E.S., Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253:1999;210-229.
27. Kennedy J.M., Zochodne D.W. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain. 123:2000;2118-2129.
28. Kim Y.B., Nikoulina S.E., Ciaraldi T.P., Henry R.R., Kahn B.B. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes [see comments]. J. Clin. Invest. 104:1999;733-741.
29. Kossila M., Sinkovic M., Karkkainen P., Laukkanen M.O., Miettinen R., Rissanen J., Kekalainen P., Kuusisto J., Yla-Herttuala S., Laakso M. Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes. 49:2000;1740-1743.
30. Krook A., Kawano Y., Song X.M., Efendic S., Roth R.A., Wallberg-Henriksson H., Zierath J.R. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes. 46:1997;2110-2114.
31. Krook A., Roth R.A., Jiang X.J., Zierath J.R., Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes. 47:1998;1281-1286.
32. Kuruvilla R., Ye H., Ginty D.D. Spatially and functionally distinct roles of the PI3-K effector pathway during NGF signaling in sympathetic neurons. Neuron. 27:2000;499-512.
33. Lee P.G., Hohman T.C., Cai F., Regalia J., Helke C.J. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve. Exp. Neurol. 170:2001;149-161.
34. Lee P.G., Cai F., Helke C.J. Streptozotocin-induced diabetes reduces retrograde axonal transport in the afferent and efferent vagus nerve. Brain Res. 941:2002;127-136.
35. Li Y., Tennekoon G.I., Birnbaum M., Marchionni M.A., Rutkowski J.L. Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival. Mol. Cell Neurosci. 17:2001;761-767.
36. Love A., Cotter M.A., Cameron N.E. Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects. Eur. J. Pharmacol. 314:1996;33-39.
37. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 46:(Suppl. 2):1997;S38-S42.
38. Maeda K., Fernyhough P., Tomlinson D.R. Regenerating sensory neurones of diabetic rats express reduced levels of mRNA for GAP-43, gamma-preprotachykinin and the nerve growth factor receptors, trkA and p75NGFR. Mol. Brain Res. 37:1996;166-174.
39. Maurel P., Salzer J.L. Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J. Neurosci. 20:2000;4635-4645.
40. Mukhopadhyay N.K., Price D.J., Kyriakis J.M., Pelech S., Sanghera J., Avruch J. An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. J. Biol. Chem. 267:1992;3325-3335.
41. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock D.A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
42. Namikawa K., Honma M., Abe K., Takeda M., Mansur K., Obata T., Miwa A., Okado H., Kiyama H. Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J. Neurosci. 20:2000;2875-2886.
43. Nikoulina S.E., Ciaraldi T.P., Carter L., Mudaliar S., Park K.S., Henry R.R. Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation. J. Clin. Endocrinol. Metab. 86:2001;4307-4314.
44. Oku A., Nawano M., Ueta K., Fujita T., Umebayashi I., Arakawa K., Kano-Ishihara T., Saito A., Anai M., Funaki M., Kikuchi M., Oka Y., Asano T. Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 280:2001;E816-824.
45. Reynolds A.J., Bartlett S.E., Hendry I.A. Signalling events regulating the retrograde axonal transport of 125I-beta nerve growth factor in vivo. Brain Res. 798:1998;67-74.
46. Rondinone C.M., Carvalho E., Wesslau C., Smith U.P. Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid, in adipocytes from subjects with Type II diabetes mellitus. Diabetologia. 42:1999;819-825.
47. Russell J.W., Feldman E.L. Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Horm. Metab. Res. 31:1999;90-96.
48. Russell J.W., Sullivan K.A., Windebank A.J., Herrmann D.N., Feldman E.L. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol. Dis. 6:1999;347-363.
49. Schmidt R.E., Plurad S.B., Saffitz J.E., Grabau G.G., Yip H.K. Retrograde axonal transport of 125I-nerve growth factor in rat ileal mesenteric nerves. Effect of streptozocin diabetes. Diabetes. 34:1985;1230-1240.
50. Shao J., Yamashita H., Qiao L., Friedman J.E. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J. Endocrinol. 167:2000;107-115.
51. Srinivasan S., Stevens M., Wiley J.W. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes. 49:2000;1932-1938.
52. Stevens M.J., Obrosova I., Cao X.H., VanHuysen C., Greene D.A. Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes. 49:2000;1006-1015.
53. Tirosh A., Potashnik R., Bashan N., Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J. Biol. Chem. 274:1999;10595-10602.
54. Toker A., Newton A.C. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem. 275:2000;8271-8274.
55. Treins C., Giorgetti-Peraldi S., Murdaca J., Van Obberghen E. Regulation of vascular endothelial growth factor expression by advanced glycation end products. J. Biol. Chem. 276:2001;43836-43841.
56. Virdee K., Xue L., Hemmings B.A., Goemans C., Heumann R., Tolkovsky A.M. Nerve growth factor-induced PKB/Akt activity is sustained by phosphoinositide 3-kinase dependent and independent signals in sympathetic neurons. Brain Res. 837:1999;127-142.
57. Vlassara H., Palace M.R. Diabetes and advanced glycation endproducts. J. Intern. Med. 251:2002;87-101.
58. Wagey R., Lurot S., Perrelet D., Pelech S.L., Sagot Y., Krieger C. Phosphatidylinositol 3-kinase activity in murine motoneuron disease: the progressive motor neuropathy mouse. Neuroscience. 103:2001;257-266.
59. Yaworsky K., Somwar R., Ramlal T., Tritschler H.J., Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia. 43:2000;294-303.
60. Zhuo H., Helke C.J. Presence and localization of neurotrophin receptor tyrosine kinase (TrkA, TrkB, TrkC) mRNAs in visceral afferent neurons of the nodose and petrosal ganglia. Mol. Brain Res. 38:1996;63-70.